$GSLR
GeoSolar Technologies Inc

2023 Q2 Form 10-Q Financial Statement

#000168316823005454 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $845.1K
YoY Change
% of Gross Profit
Research & Development $0.00
YoY Change -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $845.1K
YoY Change 92.99%
Operating Profit -$845.1K
YoY Change
Interest Expense $34.81K
YoY Change 179.65%
% of Operating Profit
Other Income/Expense, Net -$34.81K
YoY Change 179.65%
Pretax Income -$879.9K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$879.9K
YoY Change 95.39%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 61.80M shares
Diluted Shares Outstanding 61.93M shares

Balance Sheet

Concept 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.330K
YoY Change
Cash & Equivalents $9.325K
Short-Term Investments
Other Short-Term Assets $14.59K
YoY Change
Inventory
Prepaid Expenses $14.59K
Receivables
Other Receivables
Total Short-Term Assets $23.91K
YoY Change -98.58%
LONG-TERM ASSETS
Property, Plant & Equipment $464.7K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $464.7K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $23.91K
Total Long-Term Assets $464.7K
Total Assets $488.7K
YoY Change -71.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $258.7K
YoY Change 112.17%
Accrued Expenses $1.028M
YoY Change -39.52%
Deferred Revenue
YoY Change
Short-Term Debt $1.047M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.064M
YoY Change 8.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.064M
Total Long-Term Liabilities $0.00
Total Liabilities $3.064M
YoY Change 8.8%
SHAREHOLDERS EQUITY
Retained Earnings -$11.85M
YoY Change 50.92%
Common Stock $6.211K
YoY Change 3.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.576M
YoY Change
Total Liabilities & Shareholders Equity $488.7K
YoY Change -71.02%

Cashflow Statement

Concept 2023 Q2
OPERATING ACTIVITIES
Net Income -$879.9K
YoY Change 95.39%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$77.88K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 72.88K
YoY Change
NET CHANGE
Cash From Operating Activities -77.88K
Cash From Investing Activities
Cash From Financing Activities 72.88K
Net Change In Cash -5.000K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$77.88K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001838876
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-255887
dei Entity Registrant Name
EntityRegistrantName
GEOSOLAR TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4106353
dei Entity Address Address Line1
EntityAddressAddressLine1
1400 16th Street, Ste 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80202
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
932-8109
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62402000 shares
CY2023Q2 us-gaap Cash
Cash
9325 usd
CY2022Q4 us-gaap Cash
Cash
14320 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
14587 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6734 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
23912 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21054 usd
CY2023Q2 us-gaap Land
Land
464741 usd
CY2022Q4 us-gaap Land
Land
464741 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
464741 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
464741 usd
CY2023Q2 us-gaap Assets
Assets
488653 usd
CY2022Q4 us-gaap Assets
Assets
485795 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
258746 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
131454 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
197200 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
107200 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1027605 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
784815 usd
CY2023Q2 NONE Advances Current
AdvancesCurrent
534041 usd
CY2022Q4 NONE Advances Current
AdvancesCurrent
494741 usd
CY2023Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
11661 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
4823 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1035000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
995000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3064253 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2518033 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3064253 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2518033 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62102000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62102000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61702000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61702000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
6211 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6171 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9270458 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8126266 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11852269 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10164675 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2575600 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2032238 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
488653 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
485795 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
845058 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
433776 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1618908 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1124698 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4097 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7560 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
845058 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
437873 usd
us-gaap Operating Expenses
OperatingExpenses
1618908 usd
us-gaap Operating Expenses
OperatingExpenses
1132258 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
34811 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
12448 usd
us-gaap Interest Expense
InterestExpense
68686 usd
us-gaap Interest Expense
InterestExpense
21386 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34811 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12448 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-68686 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-21386 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-879869 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-450321 usd
us-gaap Net Income Loss
NetIncomeLoss
-1687594 usd
us-gaap Net Income Loss
NetIncomeLoss
-1153644 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61928667 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59850000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61835333 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59106250 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61928667 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59850000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61835333 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59106250 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2032238 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
498158 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-807725 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2341805 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
646074 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-879869 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2575600 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-545170 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
423751 usd
CY2022Q1 NONE Common Shares Issued For Subscription Receivable And Services Value
CommonSharesIssuedForSubscriptionReceivableAndServicesValue
22500 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61042 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-703323 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-741200 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
61042 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-450321 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1130479 usd
us-gaap Net Income Loss
NetIncomeLoss
-1687594 usd
us-gaap Net Income Loss
NetIncomeLoss
-1153644 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1144232 usd
us-gaap Share Based Compensation
ShareBasedCompensation
568037 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3808 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-50583 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
128887 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-44883 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
90000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-22500 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
242790 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
39742 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-77877 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-562665 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
39300 usd
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
0 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
-0 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
30000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1595 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
780 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4823 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
40000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
745000 usd
NONE Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
0 usd
NONE Proceeds From Subscription Receivable
ProceedsFromSubscriptionReceivable
975 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
283 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
72882 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
716478 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4995 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
153813 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14320 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19362 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9325 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173175 usd
us-gaap Interest Paid Net
InterestPaidNet
11652 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
NONE Expenses Paid On Companys Behalf
ExpensesPaidOnCompanysBehalf
1595 usd
NONE Expenses Paid On Companys Behalf
ExpensesPaidOnCompanysBehalf
0 usd
NONE Financing Of Prepaid Insurance Premiums
FinancingOfPrepaidInsurancePremiums
11661 usd
NONE Financing Of Prepaid Insurance Premiums
FinancingOfPrepaidInsurancePremiums
11841 usd
NONE Noncash Increase In Prepaid Expenses
NoncashIncreaseInPrepaidExpenses
0 usd
NONE Noncash Increase In Prepaid Expenses
NoncashIncreaseInPrepaidExpenses
1250000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z34ZqbEN5Cbi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_863_zJ23FcKz1x2h">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying consolidated financial statements involved the valuation of common stock and stock based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
494741 usd
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
494741 usd
NONE Advances Received In Period
AdvancesReceivedInPeriod
39300 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1035000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
995000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y6M3D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
0 usd

Files In Submission

Name View Source Status
R14.htm Edgar Link pending
0001683168-23-005454-index-headers.html Edgar Link pending
0001683168-23-005454-index.html Edgar Link pending
0001683168-23-005454.txt Edgar Link pending
0001683168-23-005454-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
geosolar_ex3101.htm Edgar Link pending
geosolar_ex3102.htm Edgar Link pending
geosolar_ex32.htm Edgar Link pending
geosolar_i10q-63023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20230630_cal.xml Edgar Link unprocessable
none-20230630_def.xml Edgar Link unprocessable
none-20230630_lab.xml Edgar Link unprocessable
none-20230630_pre.xml Edgar Link unprocessable
geosolar_i10q-63023_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending